INMD
NASDAQ
$15.36
Inmode Ltd (INMD)
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel.
Sector:
Healthcare
Industry:
Medical Devices
Hold
Target: $15.33 (-0.20%)
Market Cap
$968M
Profit Margin
25.3%
P/E Ratio
10.32
Free Cash Flow Yield
8.71%
Price Chart
Valuation
Market Cap$968M
P/E10.32
Forward P/E11.45
PEG2.90
P/S2.34
P/B1.30
Profitability
Total Revenue (TTM)$370M
Gross Profit (TTM)$292M
EBITDA$86M
Profit Margin25.3%
Operating Margin23.1%
EPS$1.48
Financial Health
Free Cash Flow Yield8.71%
Growth & Risk
EPS 5Y CAGR+8.32%
Revenue 5Y CAGR+12.44%
FCF 5Y CAGR+1.36%
Beta (5Y)1.00
Sharpe Ratio0.31